Skip to main content
. Author manuscript; available in PMC: 2020 Sep 24.
Published in final edited form as: J Am Acad Dermatol. 2013 Feb 28;68(5):834–853. doi: 10.1016/j.jaad.2012.11.002

Fig 5.

Fig 5.

Deficiency of interleukin (IL)-1 receptor antagonist (DIRA) syndrome. A, Generalized pustulosis. B, Nail dystrophy. C, Patient with DIRA before IL-1 blockade therapy. D, Same child after 5-day course of subcutaneous anakinra 100 mg/d.